Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Archives of General Psychiatry
|
September 5, 2007
Searching for rational anti N-methyl-D-aspartate treatment for depression
Guochuan E Tsai
JAMA Psychiatry
|
November 6, 2014
Impact of dietary benzoic acid on treatment response in schizophrenia--reply
Guochuan E Tsai
Journal of Psychiatry & Neuroscience : JPN
|
March 14, 2007
NMDA neurotransmission as a critical mediator of borderline personality disorder
Bernadette Grosjean, Guochuan E Tsai
Current Pharmaceutical Design
|
November 14, 2009
Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
Guochuan E Tsai, Pao-Yen Lin
Recent Patents on CNS Drug Discovery
|
November 7, 2009
Novel therapies for schizophrenia: understanding the glutamatergic synapse and potential targets for altering N-methyl-D-aspartate neurotransmission
Christina Hui, Brian Wardwell, Guochuan E Tsai
Personalized Medicine
|
May 18, 2018
Research Highlights: Genetic association of the dopamine receptor D3 Ser9Gly polymorphism with a DRD3 antagonist
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Personalized Medicine
|
May 23, 2018
Research highlights from the latest articles in 5-HTTLPR pharmacogenomics
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Molecular Diagnosis & Therapy
|
February 23, 2012
Assessing gene-gene interactions in pharmacogenomics
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Current Pharmaceutical Design
|
January 14, 2014
Assessing and treating cognitive impairment in schizophrenia: current and future
Chun-Yuan Lin, Guochuan E Tsai, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
April 6, 2011
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin, Hsien-Yuan Lane, Guochuan E Tsai
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Archives of General Psychiatry
|
September 5, 2007
Searching for rational anti N-methyl-D-aspartate treatment for depression
Guochuan E Tsai
JAMA Psychiatry
|
November 6, 2014
Impact of dietary benzoic acid on treatment response in schizophrenia--reply
Guochuan E Tsai
Journal of Psychiatry & Neuroscience : JPN
|
March 14, 2007
NMDA neurotransmission as a critical mediator of borderline personality disorder
Bernadette Grosjean, Guochuan E Tsai
Current Pharmaceutical Design
|
November 14, 2009
Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
Guochuan E Tsai, Pao-Yen Lin
Recent Patents on CNS Drug Discovery
|
November 7, 2009
Novel therapies for schizophrenia: understanding the glutamatergic synapse and potential targets for altering N-methyl-D-aspartate neurotransmission
Christina Hui, Brian Wardwell, Guochuan E Tsai
Personalized Medicine
|
May 18, 2018
Research Highlights: Genetic association of the dopamine receptor D3 Ser9Gly polymorphism with a DRD3 antagonist
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Personalized Medicine
|
May 23, 2018
Research highlights from the latest articles in 5-HTTLPR pharmacogenomics
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Molecular Diagnosis & Therapy
|
February 23, 2012
Assessing gene-gene interactions in pharmacogenomics
Hsien-Yuan Lane, Guochuan E Tsai, Eugene Lin
Current Pharmaceutical Design
|
January 14, 2014
Assessing and treating cognitive impairment in schizophrenia: current and future
Chun-Yuan Lin, Guochuan E Tsai, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
April 6, 2011
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin, Hsien-Yuan Lane, Guochuan E Tsai
Page
of 4